Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-10-11

FDA Approved: PURELAX — Supplemental Application (CVS Pharmacy)

View source ↗

Summary

FDA approved a supplemental application for PURELAX (polyethylene glycol 3350) submitted by CVS Pharmacy, updating labeling for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PURELAX (POLYETHYLENE GLYCOL 3350)

Snippet

SUPPL AP for PURELAX (POLYETHYLENE GLYCOL 3350)